Need support with enrolling patients? Get an Office Enrollment Kit.

Request a kit
Site search icon.
Mobile navigation icon.

TAKHZYRO (lanadelumab-flyo) is indicated for prophylaxis to prevent attacks of hereditary angioedema (HAE) in patients ≥2 years of age.

TAKHZYRO (lanadelumab-flyo) is indicated for prophylaxis to prevent attacks of hereditary angioedema (HAE) in patients ≥2 years of age.

TWO OPTIONS FOR ENROLLING YOUR PATIENTS TODAY

You can get your patients started on TAKHZYRO by completing the enrollment forms:

Online

To enroll your patients completely online, including in the Quick Start Program, visit the HAE Enrollment portal. No faxing required.

Enroll Online

Fax

Follow these 4 simple steps below and fax both forms to OnePath

Fax Forms

Fax option: Fax both forms to OnePath® at 1-855-ONEPATH (1-855-663-7284)

Complete the TAKHZYRO Start Form

TAKHZYRO Quick Start Program Enrollment Form

Fax the completed form(s) to OnePath®

Partner with OnePath® to support your patient

Complete the TAKHZYRO Start Form

TAKHZYRO Start Form

Start Form for TAKHZYRO® enrollment.
Download

TAKHZYRO Start Form:
Annotated Guide

TAKHZYRO® Start Form annotated guide.
Download

The TAKHZYRO Start Form acts as your patient's prescription for TAKHZYRO. It also allows your patient to authorize Takeda to provide OnePath support services (eg, access to a dedicated support manager and at-home injection training).

The TAKHZYRO Start Form requires:

  • Patient name and contact details: Include the patient's full contact information, including email address and phone number. Also include your patient’s full name at the top of each page where indicated
  • Prescriber signature: Review and consent to the prescriber certifications
  • Dosage check box: Select 1 starting dosage for new patients
  • OnePath enrollment: Remind your patient to check this box to enroll in OnePath and receive product support services such as one-on-one support with a Patient Support Manager (PSM), free injection training, and financial assistance
  • Patient signature: Your patient needs to review and consent to the patient authorization, which is critical for allowing OnePath to begin a benefits investigation without delay.

Complete the TAKHZYRO Quick Start Program Enrollment Form

TAKHZYRO Quick Start Form

TAKHZYRO® Quick Start Form.
Download
Graphic showing the process from prescribing TAKHZYRO®, to beginning the Quick Start Program, through the insurance verification process and benefits investigation, until TAKHZYRO is received by the patient. Graphic showing the process from prescribing TAKHZYRO®, to beginning the Quick Start Program, through the insurance verification process and benefits investigation, until TAKHZYRO is received by the patient.

Important guidance when completing the Quick Start Form:

  • Ensure your patient's Starting Dosage corresponds to the dosage selected in Section 4 of the TAKHZYRO Start Form
  • The prescriber's signature is required. Stamps are not acceptable

*Patients on Medicare or Medicaid are not eligible for the Quick Start Program; please have your patient contact their OnePath representative to discuss other financial options that may be available to them.

The Quick Start Program allows patients with commercial insurance* to receive up to 2 months' supply of TAKHZYRO at no cost while full benefits are being verified.

Fax the completed form(s) to: OnePath® at 1-855-OnePath (1-855-663-7284)

Getting Started with TAKHZYRO Brochure

Getting Started with TAKHZYRO® brochure.
Download

Let your patient know what to expect next:

  • If your patient consented to OnePath Product Support, let them know that a dedicated support specialist will call them within 2 to 4 days. Ask your patient to answer the call and save the OnePath number (1-866-888-0660) to their phone to avoid spam blockers
  • Additional HAE resources are available for patients to download
  • To help your patient understand next steps, provide them with the Getting Started with TAKHZYRO Brochure

Complete the prescription submission by faxing the TAKHZYRO Start Form and the TAKHZYRO Quick Start Program: Enrollment Form to OnePath at 1-855-ONEPATH (1-855-663-7284). OnePath will begin the benefits investigation process and let your office know of any next steps.

Partner with OnePath to Support your Patient

Benefits Investigation Checklist

TAKHZYRO® Benefits Verification Checklist.
Download
OnePath® logo.

Generally, a prior authorization (PA) will be required for treatment to begin, and OnePath may contact your office to share additional information that will help you complete this process. Refer to the Benefits Verification Checklist for a list of the necessary information your patient may need when submitting a PA.

If a PA is denied, you can use these templates during the appeals process. OnePath can also answer questions your office has about the denials and appeals process.

Formulary Exception Letter

Download

Letter of Intent to Treat

Download

Statement of Medical Necessity

Download

Claim Denial Letter

Download

Coverage Denial Letter

Download

Other helpful
resources

  • Learn more about OnePath Product Support for patients
  • Contact OnePath directly at 1-866-888-0660 for questions about PA requirements as well as the appeals process if a claim is denied.

HCP and patient
resources

Find materials and forms to help get patients started on TAKHZYRO.

SEE RESOURCES

EXPERT AND PATIENT INSIGHTS

Watch HAE experts discuss disease management and treatment options.

SEE VIDEOS

Starting off right
with TAKHZYRO

Help your patients prepare for treatment by establishing expectations and goals.

LEARN HOW